Trans-Atlantic Inter-Society Consensus II C and D iliac lesions can be treated by endovascular and hybrid approach: a
Maurizio Taurino1, Francesca Persiani, Cristiano Fantozzi
11Department of Vascular Surgery, Sant'Andrea Hospital, University of Rome-"La Sapienza", Rome, Italy.
Insights
Endovascular and hybrid treatments are effective for severe aortoiliac lesions (TASC II C-D), challenging traditional guidelines. Individual lesion analysis is crucial for successful outcomes in complex cases.
Area of Science:
- Vascular Surgery
- Endovascular Interventions
- Aortoiliac Disease Management
Background:
- Trans-Atlantic Inter-Society Consensus (TASC) II guidelines traditionally recommend open surgical repair for TASC II type C and D aortoiliac lesions.
- Complex aortoiliac occlusive disease presents significant challenges for revascularization.
- Evaluating less invasive treatment options is critical for improving patient outcomes.
Purpose of the Study:
- To assess the long-term efficacy of endovascular and hybrid revascularization for TASC II type C and D aortoiliac lesions.
- To emphasize the importance of individualized lesion assessment over strict adherence to TASC II guidelines.
- To determine the safety and patency rates of these advanced treatment modalities.
Main Methods:
- A retrospective analysis of 50 patients with TASC II C and D aortoiliac lesions treated between January 2008 and December 2012.
- Patients underwent either endovascular (76%) or hybrid (24%) treatment.
- A comprehensive postoperative surveillance program was implemented, with regular follow-up intervals.
Main Results:
- 100% technical success rate was achieved in all treated patients.
- Low postoperative complication rate of 4% was observed.
- Excellent long-term patency rates: primary patency of 86.6% at 3 years and secondary patency of 97.7% at 3 years.
- High survival (91.1% at 3 years) and 100% limb salvage rates were reported.
Conclusions:
- Endovascular or hybrid treatment represents a viable and effective alternative for TASC II type C and D aortoiliac lesions, contrary to conventional guidelines.
- Hybrid approaches can significantly improve distal perfusion (runoff), which is vital for treating multilevel disease.
- Individualized assessment of each iliac axis is paramount for selecting the optimal treatment strategy in complex cases.
Purpose:
To evaluate the long-term results of endovascular and hybrid treatment in patients with Trans-Atlantic Inter-Society Consensus (TASC) II type "C" and "D" aortoiliac lesions and to highlight, in contrast to TASC II guidelines, the importance to analyze individually the lesions of a single iliac axis.
Methods:
From January 2008 to December 2012, 50 patients with TASC II type C and D aortoiliac lesions underwent endovascular or hybrid treatment. In 38 patients (76%), the lesions were treated by endovascular approach, while in 12 (24%) patients surgical treatment was adopted. All patients underwent a postoperative surveillance program at 1, 3, and 6 months for the first year and every 6 months thereafter.
Results:
Technical success was achieved in all patients (100%). The postoperative complication rate was 4%. Primary patency rate was 93.3% at 1 year, 90.2% at 2 years, and 86.6% at 3 years. Cumulative secondary patency rate was 97.7% at 1, 2, and 3 years. Survival after 1 and 2 years was 94.8% and after 3 years was 91.1%. Limb salvage was 100% for the entire period of follow-up.
Conclusions:
In contrast to TASC II guidelines, the endovascular or hybrid treatment should be considered a valid approach for type C and D lesions. The hybrid treatment, in selected cases, is an effective method to improve the runoff, which plays a key role in the success of the treatment of multilevel stenoocclusive lesions. In TASC II C to D iliac lesions, a specific overview of each axis is necessary in order to select the most appropriate treatment.
More Related Videos
Related Concept Videos
Aneurysm III: Interprofessional Care
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care


